Edgewise Therapeutics · 4 days ago
Director, Head of Statistical Programming
Maximize your interview chances
BiopharmaBiotechnology
Insider Connection @Edgewise Therapeutics
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Work closely with the Edgewise Therapeutics cross-functional team, including, but not limited to Statistics, Medical, Clinical Operations, and Data Management;
Comply with applicable national and international laws, regulations, including, but not limited to applicable Good Clinical Practices (GCPs), and Data Privacy Regulations;
Comply with Edgewise Therapeutics policies, standard operating procedures, and other written instructions;
Demonstrate effective leadership and working skill in teamwork, delegation, organization and coordination;
Demonstrate a high level of professionalism and personal integrity when representing the Company;
Assisting with the selection of Contract Research Organizations (CROs) or other vendors for statistical, programming activities, covering both programming for data standards compliance, as well as tables, listings and figures (TLFs);
Oversight of all statistical programming activities done by co-development partners, CROs or other vendor(s). This oversight will include but not be limited to:
Review and validation of technical programming specifications and programs
Review of SDTM and ADaM datasets
Quality check of SAP specific tables, listings, and figures
Filing of all statistical programming related study documentation;
Ensures programs and processes are developed, implemented, and effectively administered;
Oversees the investigation and implementation of new procedures and technologies relating to statistical programming;
Lead SOP development for standardization of statistical programming processes. Ensure that appropriate SOPs and guidelines are available, understood and followed;
Input and accountability for development of timelines, project management of all end-to-end statistical programming deliverables in collaboration with cross-functional team members and vendors on assigned studies;
Ensures that out-sourced statistical programming tasks are performed according to GCP, approved SOPs, and protocol;
Manages performance and quality issues with vendors and escalates when needed;
Participates as subject matter expert during regulatory inspections and/or vendor audits as needed;
Provides input into the budget for any statistical programming software, systems, and/or activities;
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Education: BS/BA at minimum with MS preferred and 10+ years of experience in Biotech and/or Pharmaceutical industries, or equivalent
Extensive statistical programming and clinical trial knowledge
Management roles within Biometrics, with effective people management, interpersonal, communication, and negotiation skills
Expert-level experience as SAS programmer
Subject-matter expert regarding CDISC-SDTM/ADaM data standard specifications
Team player, capable of adapting to changing demands and aggressive timelines
Experience working with safety data and coding dictionaries (MedDRA and WHODRL)
Familiarity with XML, and XML validation tools
Experience integrating datasets across multiple clinical studies to support an ISS/ISE
Preferred
Interpersonal skills and excellent written/oral communication skills, including grammatical and technical writing skills
Ability to self-motivate and lead with confidence is critical
Excellent organizational and time management skills, sense of urgency
Strong analytical and problem-solving skills
Project Management skills
Benefits
Health benefits
A discretionary bonus plan
Stock option grants
A stock purchase plan
A 401(k) with match
Paid time off
Company
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Funding
Current Stage
Public CompanyTotal Funding
$538.5MKey Investors
Viking Global Investors
2024-01-19Post Ipo Equity· $240M
2022-09-13Post Ipo Equity· $138M
2021-03-26IPO
Leadership Team
Recent News
Company data provided by crunchbase